Data Analytics

Hospitals and health systems use current and past data from its informatics systems to find trends, draw conclusions and identify the potential for improvement outcomes in patients and populations, and to support business decision-making. In patient care, data analytics can show areas  that need improvement, and bottlenecks to faster and more accurate diagnoses. On the business side, health system data can be leveraged to lower costs, maximize revenue, streamline and improve operations. Data is increasingly being used to look at the larger picture of population health to identify traits that can flag patients that may need additional resources to prevent readmissions. It can also help identify patients at high risk for some diseases that can be contacted about additional screenings for improved preventative care.

Epic sued by interoperability startup following dispute over patient data

Particle Health has accused Epic Systems of monopolistic business practices that hinder data-driven initiatives to improve patient care. Epic calls the complaint “baseless.” 

underutilized healthcare data

So much healthcare data, so many missed opportunities

Four of five hospital leaders trust the accuracy of their institution’s data. Yet almost half of useable data gets underutilized if not completely untapped for guiding business and clinical decisions.

bipartisan house task force on artificial intelligence

House to hold hearing on new patient data rights legislation

The bipartisan American Privacy Rights Act (APRA) would allow consumers to access and delete much of their personal data being held by private companies.

Video of Kateita Hasanovic, RN, senior director, clinical EHR applications at Baptist Health, Jacksonville, Florida, explains how her large health system consolidated its Epic EHR and patient medication history.

How medication reconciliation data consolidation in the EHR enables better patient care

Baptist Health in Jacksonville, Florida, consolidated patient medication history from numerous facilities into one location in its Epic EHR to improve patient safety and allow data analytics.

ransomware cybercrime

Hospital trio learns cybersecurity lessons the hard way

How quickly a hospital recovers from a ransomware cyberattack has a lot to do with how thoroughly the hospital prepared ahead of time for just such an event.

Thumbnail

Patients admitted with C. diff not a significant source of in-hospital transmission

Hospital patients who test positive for Clostridioides difficile immediately upon admission but show no symptoms are highly unlikely to spread the germ to other inpatients.

Bradley Hunter, vice president for value-based care and core solutions at KLAS Research, outlines several key, overarching health information technology trends at the Health Information management Systems Society (HIMSS) 2023 meeting. #HIMSS #HIMSS23

KLAS explains key health IT trends at HIMSS 2023

Bradley Hunter, vice president for value-based care and core solutions at KLAS Research, outlines the key, overarching health information technology trends seen at the Health Information Management Systems Society (HIMSS) 2023 meeting. 

Emit Trivedi, Healthcare Information Management Systems Society (HIMSS) director of informatics and health IT standards, discussed these challenges of next-level interoperability with Health Exec at the HIMSS 2023 annual meeting. #HIMSS #HIMSS23 #HIMS2023 #interoperability

What missing pieces remain in health IT interoperability?

Amit Trivedi, HIMSS director of informatics and health IT standards, explains the remaining gaps in interoperability and how it remains a moving target.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.